Adc Therapeutics Sa's ability to collect accounts receivable sequentially worsen to 2.86, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Adc Therapeutics Sa's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 128 days, from 126 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 396 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2691, from overall ranking in the first quarter 2026 at 2896.

What is Receivable Turnover Ratio?
What is Adc Therapeutics Sa Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADCT Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	7.07 %	-2.26 %	43.32 %	-4.63 %	14.5 %
Y / Y Revenue Change	2.17 %	-9.47 %	36.36 %	-11.03 %	8.21 %
Receivable Turnover Ratio (TTM)	2.86	2.9	2.96	2.97	3.02
ADCT's Total Ranking	# 2691	# 2896	# 2197	# 2919	# 2865
Accounts Receivable average collection period days	127	126	123	123	121
Seq. Receivable Change	-9.7 %	6.62 %	27.05 %	-12.47 %	-17.56 %
Seq. Revenue Change	-7.69 %	-9.57 %	40.37 %	-12.8 %	-18.21 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 120
Healthcare Sector	# 397
Overall Market	# 2691

Receivable Turnover Ratio Statistics
High	Average	Low
0.87	0.56	0.06
(Sep. 30, 2009)		(Dec 31 2021)

ADCT Company Profile • Back to ADCT Efficiency Comparisons • Compare ADCT Receivables Turnover Ratio to its Competitors

Financial Statements
Adc Therapeutics Sa's Accounts Receivable	$ 28 Millions	Visit ADCT's Balance sheet
Adc Therapeutics Sa's Sales TTM	$ 80 Millions	Visit ADCT's Income Statement
Sources of ADCT's Revenues		Visit ADCT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADCT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADCT's Growth Rates	ADCT's Roa	ADCT's Inventory Turnover Ratio	ADCT's Dividend Comparisons
ADCT's Profitability Ratios	ADCT's Roi	ADCT's Asset Turnover Ratio	ADCT's Dividend Growth
ADCT's Valuation Ratios	ADCT's Roe	ADCT's Financial Strength Ratios	ADCT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Pacs Group Inc	7.78	$ 5,551.038 Millions	$ 713.483 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Idexx Laboratories Inc	7.65	$ 4,553.792 Millions	$ 595.549 Millions
Sharps Technology Inc	7.65	$ 2.468 Millions	$ 0.323 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Protalix Biotherapeutics inc	7.55	$ 80.619 Millions	$ 10.677 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Novocure Limited	7.46	$ 699.193 Millions	$ 93.686 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions
Transmedics Group Inc	7.43	$ 668.468 Millions	$ 89.962 Millions
Beta Bionics Inc	7.43	$ 119.513 Millions	$ 16.092 Millions
Renovorx Inc	7.40	$ 1.976 Millions	$ 0.267 Millions
Maravai Lifesciences Holdings Inc	7.39	$ 207.886 Millions	$ 28.147 Millions
Lucid Diagnostics Inc	7.33	$ 5.445 Millions	$ 0.742 Millions
Foxo Technologies Inc	7.27	$ 24.846 Millions	$ 3.420 Millions
Safe Pro Group Inc	7.23	$ 2.881 Millions	$ 0.399 Millions
Rhythm Pharmaceuticals Inc	7.18	$ 239.918 Millions	$ 33.429 Millions
Travere Therapeutics Inc	7.10	$ 591.330 Millions	$ 83.339 Millions
Angiodynamics Inc	7.08	$ 317.726 Millions	$ 44.853 Millions
Pulmonx Corporation	7.07	$ 87.393 Millions	$ 12.356 Millions
Sutro Biopharma Inc	6.98	$ 45.702 Millions	$ 6.545 Millions
Edwards Lifesciences Corporation	6.98	$ 6,512.500 Millions	$ 933.400 Millions
Beyond Air Inc	6.98	$ 6.677 Millions	$ 0.957 Millions
Quidelortho Corp	6.92	$ 2,674.200 Millions	$ 386.400 Millions
Myriad Genetics Inc	6.91	$ 805.900 Millions	$ 116.650 Millions
Ceribell Inc	6.90	$ 101.804 Millions	$ 14.749 Millions
Stryker Corp	6.89	$ 25,837.000 Millions	$ 3,749.000 Millions
Nephros Inc	6.83	$ 21.686 Millions	$ 3.173 Millions

Date modified: 2026-09-02T20:46:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.